Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Vijaya Diagnostic Centre
Mid Cap•2,218 Employees•IPO 2021
Current Price
₹938.20
-3.7 (-0.39%)Updated
Today's Range
926.7
₹938.20
953.3
52 Week Range
52W Low₹813.15
52W High₹1180.00
₹938.20
Downside15.38%
Upside25.77%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹10,259.24 Cr
Market Cap
Total market value of companyP/E Ratio
67.76
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
11.87
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹14.74
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
9.38%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
20.90%
ROCE
Return on Capital Employed. >15% is goodNet Margin
20.69%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
17.81%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
15.00%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
20.40%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
22.30%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.40
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹77.53
Book Value
Net asset value per shareDividend Yield
0.20%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
52.60%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Strong ROE (19.00%) and ROCE (20.90%) indicate efficient capital utilization.
- •Impressive quarterly sales (20.40%) and profit (22.30%) growth.
Weaknesses
5 points- •High Price-to-Earnings (70.07) suggests potential market overvaluation.
- •Elevated Price-to-Book Value (13.21) indicates a premium valuation.
Opportunities
5 points- •Robust healthcare service industry growth drives demand for diagnostics.
- •Well-positioned for market expansion and service diversification.
Threats
3 points- •Highly competitive diagnostic services market with established players.
- •Regulatory changes, including pricing controls, could impact profitability.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1005.30 | +₹67.10 | +7.15% |
| R3 | ₹978.70 | +₹40.50 | +4.32% |
| R2 | ₹966.00 | +₹27.80 | +2.96% |
| R1 | ₹952.10 | +₹13.90 | +1.48% |
| PIVOT | ₹939.40 | 1.20 | 0.13% |
| CURRENT | ₹938.20 | - | - |
| S1 | ₹872.30 | -₹65.90 | -7.02% |
| S2 | ₹898.90 | -₹39.30 | -4.19% |
| S3 | ₹912.80 | -₹25.40 | -2.71% |
| S4 | ₹925.50 | -₹12.70 | -1.35% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+234.1% vs avg
3.68L
(18 Mar 2026)Delivery %+23.5% vs avg
78.9%
(18 Mar 2026)Avg Volume (20D)20-day average
1.10L
(18 Feb - 18 Mar)Avg Delivery %Trend ↓
55.3%
(18 Feb - 18 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Dr Lal Pathlabs Ltd
24,046.66 ₹ Cr
Best Profit Growth
Thyrocare Technologies Ltd
79.90 %
Highest Dividend Yield
Thyrocare Technologies Ltd
1.66 %
Peer Comparison
| Company Name |
|---|
 Krsnaa Diagnostics Ltd |
 Dr Lal Pathlabs Ltd |
 Metropolis Healthcare Ltd |
 Suraksha Diagnostic Ltd |
 Thyrocare Technologies Ltd |
About
Vijaya Diagnostic Centre Ltd
Vijaya Diagnostic Centre Limited is a prominent provider of diagnostic healthcare services in India, primarily operating within the country. Their extensive service offerings cater to a wide range of patient needs, encompassing a comprehensive suite of diagnostic tests and imaging procedures.
The core of Vijaya's business lies in its laboratory services. This includes a broad spectrum of clinical pathology tests, microbiology analyses, hematology assessments, serology studies, histopathology examinations, and cytogenetic investigations. Furthermore, they offer advanced biochemical testing and molecular diagnostics, providing a deep and detailed analysis of patient samples.
Beyond laboratory work, Vijaya Diagnostic Centre offers a complete range of sophisticated medical imaging services. This includes Computed Tomography (CT) scans, Magnetic Resonance Imaging (MRI) scans, including advanced 3T MRI technology, ultrasound imaging, and X-ray procedures. They also provide specialized imaging services in cardiology, gastroenterology, and nuclear medicine, including Positron Emission Tomography/Computed Tomography (PET/CT) scans.
Complementing its diagnostic services, Vijaya also provides convenient health checkup packages designed for preventative care and early disease detection. The company further enhances accessibility through its home sample collection service, bringing convenience and ease to patients needing diagnostic tests.
Established in 1981 and headquartered in Hyderabad, India, Vijaya Diagnostic Centre Limited has a long history of providing high-quality diagnostic services. Their comprehensive range of offerings, from basic laboratory tests to advanced imaging, positions them as a significant player in the Indian healthcare landscape.
COMPANY FACTS - VIJAYA
Registered Address
6-3-883/F, Ground Floor, FPA Building,, Near Topaz Building, Punjagutta,
Hyderabad
TELANGANA
IN
Tel: 914023420411
Website:https://www.vijayadiagnostic.com/
Investor Relations:http://www.vijayadiagnostic.com/investors/annual-reports
Company Details
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 2,218
IPO Date: 14/09/2021
MANAGEMENT - VIJAYA
Dr. Sura Reddy
Executive Chairman of the Board, Founder
Ms. Sura Reddy
Chief Executive Officer, Managing Director, Executive Director
Mr. S. Ramchandra Reddy
Interim Chief Financial Officer
Mr. Hansraj Rajput
Company Secretary & Compliance Officer
Mr. Sunil Kondapally
Executive Director
Mrs. Sura Reddy
Non-Executive Non-Independent Director
Dr. Manjula Anagani
Non-Executive Independent Director
Mr. Chavali Murthy
Non-Executive Independent Director
Dr. Duvvur Reddy
Non-Executive Independent Director
Mr. Shekhar Singh
Non-Executive Independent Director
Investor Questions Answered
Vijaya Diagnostic Centre Ltd (VIJAYA) Stock FAQs
Get answers to the most common questions about Vijaya Diagnostic Centre Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Vijaya Diagnostic Centre Ltd (VIJAYA) is ₹938.2. Today, the stock has declined by ₹3.70 (0.39%), trading in a range of ₹926.7 to ₹953.3. The stock opened at ₹941.9 with a trading volume of 3,68,373 shares.
Vijaya Diagnostic Centre Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,259.24 crores, P/E ratio of 67.76, ROE of 9.38%, and ROCE of 20.90%. The dividend yield stands at 0.20%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Vijaya Diagnostic Centre Ltd (VIJAYA) is ₹1,180, while the 52-week low is ₹813.15. Currently trading at ₹938.2, the stock is 34.1% away from its 52-week low and 20.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Vijaya Diagnostic Centre Ltd stock at ₹938.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 67.76 and P/B ratio of N/A. Today's performance shows a loss of 0.39%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Vijaya Diagnostic Centre Ltd offers a dividend yield of 0.20%, which means for every ₹100 invested at the current price of ₹938.2, you can expect to receive approximately ₹0.20 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Vijaya Diagnostic Centre Ltd's key financial metrics include: P/E Ratio: 67.76, P/B Ratio: N/A, ROE: 9.38%, ROCE: 20.90%, Dividend Yield: 0.20%, EPS: ₹14.74, Book Value: ₹77.53, Debt-to-Equity: 0.40, and Current Ratio: N/A. The company's market cap stands at ₹10,259.24 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Vijaya Diagnostic Centre Ltd stock opened at ₹941.9 and is currently trading at ₹938.2, showing a decline of ₹3.70 (0.39%). The intraday high is ₹953.3 and low is ₹926.7. The trading volume stands at 3,68,373 shares, indicating moderate market participation today.
Vijaya Diagnostic Centre Ltd has a Price-to-Earnings (P/E) ratio of 67.76, which means investors are willing to pay ₹67.76 for every ₹1 of earnings. With an EPS of ₹14.74, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Vijaya Diagnostic Centre Ltd has a market capitalization of ₹10,259.24 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹938.2) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Vijaya Diagnostic Centre Ltd has a book value of ₹77.53 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹938.2, which is 1110.1% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Vijaya Diagnostic Centre Ltd has a Return on Equity (ROE) of 9.38% and Return on Capital Employed (ROCE) of 20.90%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Vijaya Diagnostic Centre Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Vijaya Diagnostic Centre Ltd has a debt-to-equity ratio of 0.40, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Vijaya Diagnostic Centre Ltd has an Earnings Per Share (EPS) of ₹14.74, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹938.2 and P/E ratio of 67.76, investors are paying 67.76 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Vijaya Diagnostic Centre Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Vijaya Diagnostic Centre Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Vijaya Diagnostic Centre Ltd stock, consider: 1) Fundamental Analysis - Review P/E (67.76), ROE (9.38%), debt-to-equity (0.40), and growth rates. 2) Technical Analysis - Check 52-week range (₹813.15 - ₹1180.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹938.20) with book value (₹77.53) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Vijaya Diagnostic Centre Ltd share is ₹1.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹938.2 is 93720x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Vijaya Diagnostic Centre Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹813.15 - ₹1180.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.40 indicates leverage. 4) Liquidity Risk - Based on trading volume of 3,68,373 shares. 5) Valuation Risk - P/E of 67.76 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Vijaya Diagnostic Centre Ltd operates in the industry with key metrics: P/E ratio of 67.76, ROE of 9.38%, market cap of ₹10,259.24 crores, and dividend yield of 0.20%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.40), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Vijaya Diagnostic Centre Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹938.2, with a 52-week range of ₹813.15 to ₹1180.00. Based on fundamentals like P/E (67.76), ROE (9.38%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Vijaya Diagnostic Centre Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹938.20. 2) Fundamental Deterioration - Declining ROE (currently 9.38%), increasing debt (D/E: 0.40), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Vijaya Diagnostic Centre Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.20%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu